Current Issue January 2012, Vol. 102, No. 1

Issue Highlights

Original articles

Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: A phase II trial
January 2012(Vol. 102 | No. 1 | Pages 4-9)
Jin-luan Li, Jia-fu Ji, Yong Cai, Xiao-fan Li, Yong-heng Li, Hao Wu, Bo Xu, Fang-yuan Dou, Zi-yu Li, Zhao-de Bu, Ai-wen Wu, Ivan W.K. Tham

Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer – A two stage phase II clinical trial
January 2012(Vol. 102 | No. 1 | Pages 10-13)
Gudrun Resch, Alexander De Vries, Dietmar Öfner, Wolfgang Eisterer, Hans Rabl, Michael Jagoditsch, Michael Gnant, Josef Thaler, on behalf of the Austrian Breast and Colorectal Cancer Study Group

Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands
January 2012(Vol. 102 | No. 1 | Pages 14-21)
Jasper Nijkamp, Danielle F.M. de Haas-Kock, Jannet C. Beukema, Karen J. Neelis, Dankert Woutersen, Heleen Ceha, Tom Rozema, Annerie Slot, Hanneke Vos-Westerman, Martijn Intven, Patty H. Spruit, Yvette van der Linden, Debby Geijsen, Karijn Verschueren, Marcel B. van Herk, Corrie A.M. Marijnen

Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03
02 February 2012
Ivan Toledano, Pierre Graff, Antoine Serre, Pierre Boisselier, René-Jean Bensadoun, Cécile Ortholan, Pascal Pommier, Séverine Racadot, Gilles Calais, Marc Alfonsi, Veronique Favrel, Philippe Giraud, Michel Lapeyre
Abstract: Background and purpose: In 2003, the French Authority for Health (HAS) recommended the use of intensity modulated radiotherapy (IMRT) in prospective trial before its routine use. The Oncolog...
Managing a national radiation oncologist workforce: A workforce planning model
02 February 2012
Teri Stuckless, Michael Milosevic, Catherine de Metz, Matthew Parliament, Brent Tompkins, Michael Brundage
Abstract: Purpose: The specialty of radiation oncology has experienced significant workforce planning challenges in many countries. Our purpose was to develop and validate a workforce-planning model t...
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
02 February 2012
Herbert H. Loong, Brigette B.Y. Ma, Sing-Fai Leung, Frankie Mo, Edwin P. Hui, Michael K. Kam, Stephen L. Chan, Brian K.H. Yu, Anthony T.C. Chan
Abstract: Background and purpose: Concurrent chemoradiotherapy (CRT) confers survival benefit over radiotherapy (RT) alone in the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC). T...
Urinary morbidity after permanent prostate brachytherapy – Impact of dose to the urethra vs. sources placed in close vicinity to the urethra
02 February 2012
Michael Pinkawa, Richard Holy, Marc D. Piroth, Jens Klotz, David Pfister, Axel Heidenreich, Michael J. Eble
Abstract: Background and purpose: The impact of the dose to the urethra and sources placed close to the urethra on urinary morbidity after permanent prostate brachytherapy (PPB) is not well known. Mat...
A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis
02 February 2012
Kazuki Terashima, Yusuke Demizu, Naoki Hashimoto, Dongcun Jin, Masayuki Mima, Osamu Fujii, Yasue Niwa, Kento Takatori, Naoto Kitajima, Sachiyo Sirakawa, Ku Yonson, Yoshio Hishikawa, Mitsuyuki Abe, Ryohei Sasaki, Kazuro Sugimura, Masao Murakami
Abstract: Purpose: We conducted the study to assess the feasibility and efficacy of gemcitabine-concurrent proton radiotherapy (GPT) for locally advanced pancreatic cancer (LAPC). Materials and method...

View More Articles in Press...

1

Article Title	Author(s)	Type	Pages
EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach August 2009 (Vol. 92 \| No. 2 \| Pages 164-175) Abstract Full Text PDF (2033 KB)	Oscar Matzinger, Erich Gerber, Zvi Bernstein, Philippe Maingon, Karin Haustermans, Jean François Bosset, Akos Gulyban, Philip Poortmans, Laurence Collette, Abraham Kuten et al.	Full-length article	164-175
Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy September 2011 (Vol. 100 \| No. 3 \| Pages 333-343) Abstract Full Text PDF (258 KB)	Christine Haie-Meder, Frank-André Siebert, Richard Pötter	Full-length article	333-343
Radiation-induced heart morbidity after adjuvant radiotherapy of early breast cancer – Is it still an issue? August 2011 (Vol. 100 \| No. 2 \| Pages 157-159) Full Text PDF (144 KB)	Birgitte Offersen, Inger Højris, Marie Overgaard	Editorial	157-159
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients July 2009 (Vol. 92 \| No. 1 \| Pages 4-14) Abstract Full Text PDF (478 KB) Supplemental Materials	Jean-Pierre Pignon, Aurélie le Maître, Emilie Maillard, Jean Bourhis, on behalf of the MACH-NC Collaborative Group et al.	Full-length article	4-14
Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention August 2011 (Vol. 100 \| No. 2 \| Pages 160-166) Abstract Full Text PDF (186 KB)	Nicolaus Andratschke, Jean Maurer, Michael Molls, Klaus-Rüdiger Trott	Review article	160-166

1

Most Read lists are compiled every quarter.

Publishing Information

Radiotherapy & Oncology is published by Elsevier.

Click here to read a selection of papers from the launch of Radiotherapy in 1983 to 2011

About Radiotherapy & Oncology

Radiotherapy & Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning.

More